Frontiers in Oncology (Mar 2023)
Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer
- Gianluca Mauri,
- Gianluca Mauri,
- Gianluca Mauri,
- Giorgio Patelli,
- Giorgio Patelli,
- Viviana Gori,
- Viviana Gori,
- Calogero Lauricella,
- Benedetta Mussolin,
- Alessio Amatu,
- Katia Bencardino,
- Federica Tosi,
- Erica Bonazzina,
- Emanuela Bonoldi,
- Alberto Bardelli,
- Alberto Bardelli,
- Salvatore Siena,
- Salvatore Siena,
- Andrea Sartore-Bianchi,
- Andrea Sartore-Bianchi
Affiliations
- Gianluca Mauri
- Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy
- Gianluca Mauri
- IFOM, Istituto Fondazione di Oncologia Molecolare ETS, Milan, Italy
- Gianluca Mauri
- Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Giorgio Patelli
- Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy
- Giorgio Patelli
- Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Viviana Gori
- Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy
- Viviana Gori
- Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Calogero Lauricella
- Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Benedetta Mussolin
- Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy
- Alessio Amatu
- Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Katia Bencardino
- Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Federica Tosi
- Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Erica Bonazzina
- Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Emanuela Bonoldi
- Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Alberto Bardelli
- Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Torino, Italy
- Alberto Bardelli
- Department of Oncology, Università degli Studi di Torino, Turin, Italy
- Salvatore Siena
- Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy
- Salvatore Siena
- Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy
- Andrea Sartore-Bianchi
- Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy
- Andrea Sartore-Bianchi
- Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy
- DOI
- https://doi.org/10.3389/fonc.2023.1147497
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
